Pulse - Ezetimibe reduces vascular events

Links shared publicly online about this topic.

  • 692
    total visits

Pulse - Ezetimibe reduces vascular events

pulsetoday.co.uk

Pulse - Ezetimibe reduces vascular events

View full resource at pulsetoday.co.uk

Tags: Cholesterol Medication, Zetia, Event

  • Share

Most Recently Shared on November 29, 2010 at 10:17 am By:

pulsetoday PulseToday

Ezetimibe reduces vascular events: A new investigational study appears to have shown for the first time that pre... http://bit.ly/eC68dI

1 year ago...

Merck's Blood Thinner Shows Reduced Heart Events, But Increased Bleeding

rttnews.com — “Drugmaker Merck & Co. (MRK) Saturday said its experimental blood thinner vorapaxar in combination with standard of care was seen to significantly reduce cardio vascular events in heart patients, but saw an increase in bleeding especially in those who have had a stroke.View full resource at rttnews.com

  • View Related
  • Share

Most Recently Shared on March 25, 2012 at 5:05 am By:

tomheston Tom Heston, MD Doctor, Family Medicine Doctor, and Physician

Merck's Blood Thinner Shows Reduced Heart Events, But Increased Bleeding - RTT News http://t.co/yedpZo95 #health

3 weeks ago...

Novel Antiplatelet Agent Reduces CV Events But Increases Bleeding - Forbes

forbes.com — “Vorapaxar, the novel antiplatelet agent from Merck, appears to effectively reduce cardiovascular death and ischemic events in patients with MI, ischemic stroke, or peripheral vascular disease, but its potential utility is clouded by bleeding complications, including intracranial hemorrhage. Results from the TRA 2P-TIMI 50 (Thrombin Receptor Antagonist in Secondary Prevention of [...]View full resource at forbes.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 2:07 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Novel Antiplatelet Agent Reduces CV Events But Increases Bleeding: Vorapaxar, the novel antiplatelet agent... http://t.co/UiSxUrWH #drug

3 weeks ago...

Meta-Analysis Adds New Evidence For Cancer Benefits Of Daily Aspirin - Forbes

forbes.com — “Although daily aspirin was originally proposed to reduce cardiovascular events, the effects on cancer of daily aspirin have become increasingly apparent while the vascular benefits, especially in primary prevention, have become less clear. Now a new meta-analysis in the Lancet adds significantly new details to our understanding about the effects [...]View full resource at forbes.com

  • View Related
  • Share

Most Recently Shared on March 21, 2012 at 12:58 am By:

Cancer_Wisdom Cancer OW OW Health

Meta-Analysis Adds New Evidence For Cancer Benefits Of Daily Aspirin: Although daily aspirin was originally prop... http://t.co/0WlrQvCO

3 weeks ago...

Meta-Analysis Adds New Evidence For Cancer Benefits Of Daily Aspirin - Forbes

forbes.com — “Although daily aspirin was originally proposed to reduce cardiovascular events, the effects on cancer of daily aspirin have become increasingly apparent while the vascular benefits, especially in primary prevention, have become less clear. Now a new meta-analysis in the Lancet adds significantly new details to our understanding about the effects [...]View full resource at forbes.com

  • View Related
  • Share

Most Recently Shared on March 20, 2012 at 11:02 pm By:

DrOncol Noushin Hart MD Radiation Oncologist, Physician, Doctor, and Oncologist

Meta-Analysis Adds New Evidence For Cancer Benefits Of Daily Aspirin - Forbes http://t.co/57npZlPn

4 weeks ago...

Full coverage of post-MI drugs reduced vascular event rates, out-of-pocket costs

endocrinetoday.com — “AHA Scientific Sessions 2011 ORLANDO, Fla. — Eliminating co-payments for post-MI secondary prevention drugs improved adherence, reduced ratesView full resource at endocrinetoday.com

  • View Related
  • Share

Most Recently Shared on November 17, 2011 at 4:31 pm By:

EndocrineToday Endocrine Today Health News

Full coverage of post-MI drugs reduced vascular event rates, out-of-pocket costs #AHA11 http://t.co/5rURDLne

5 months ago...

Eliminating Co-Payments For Heart Attack Medications Increases Adherence And Reduces Major Vascular Events

medicalnewstoday.com — “The use of specific medications following a heart attack has been shown to reduce cardiovascular events and mortality, however; while highly effective, the rate of adherence to these medications iView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 16, 2011 at 9:07 am By:

mnt_cardiovasc MNT Cardiovascular Health News

Eliminating Co-Payments For Heart Attack Medications Increases Adherence And Reduces Major Vascular Events http://t.co/hIG1cNov

5 months ago...

Hospital Team Significantly Reduced Risk Of Further Vascular Events After 'Mini Strokes'

medicalnewstoday.com — “Patients who had a transient ischaemic attack (TIA), sometimes referred to as a mini stroke, were much less likely to experience further vascular events in the first year if their care was co-orView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 28, 2011 at 9:05 am By:

mnt_vascular MNT Vascular Health News

Hospital Team Significantly Reduced Risk Of Further Vascular Events After 'Mini Strokes' http://t.co/xgas9aE2 #vascular

6 months ago...

Special team care reduces cumulated stroke risk after transient ischaemic attacks

news-medical.net — “Patients who had a transient ischaemic attack (TIA), sometimes referred to as a "mini stroke", were much less likely to experience further vascular events in the first year if their care was co-ordinated by a special hospital team. That is the key finding from a study published in the November issue of the European Journal of Neurology.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on October 28, 2011 at 6:10 am By:

Stroke_News News-Medical.Net Health News

Stroke News: Special team care reduces cumulated stroke risk after transient ischaemic attacks: Patients who had... http://t.co/M5nimHf2

6 months ago...

Reducing Vascular Events Risk in Patients With Dyslipidaemia - QualityPoint Technologies

qualitypointtech.net — “The authors present methods of risk assessment for cardiovascular events in patients with dyslipidemia, as well as guidelines for risk reduction. Therapeutic Advances in Chronic DiseaseView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on October 7, 2011 at 10:45 am By:

MedicalFeed MedicalFeed Health News Feed

Reducing Vascular Events Risk in Patients With Dyslipidaemia: The authors present methods of risk assessment for c... http://t.co/p9gTefWo

6 months ago...

Reduce Your Heart Disease Risk with a Free Event in September « Heart & Vascular

advancingyourhealth.org — “Reduce Your Heart Disease Risk with a Free Event in September « Heart & VascularView full resource at advancingyourhealth.org

  • View Related
  • Share

Most Recently Shared on September 5, 2011 at 5:10 pm By:

Reduce Your Heart Disease Risk with a Free Event in September « Heart & Vascular

advancingyourhealth.org — “Reduce Your Heart Disease Risk with a Free Event in September « Heart & VascularView full resource at advancingyourhealth.org

  • View Related
  • Share

Most Recently Shared on August 31, 2011 at 6:40 pm By:

emoryhealthcare Emory Healthcare Healthcare System

Four easy opportunities in to reduce your risk for heart disease: http://t.co/hwLxSb1 #events #atlanta

7 months ago...

Statins may reduce risk of recurrent vascular events in young stroke patients - - ModernMedicine

modernmedicine.com — “Young adults treated with a statin after a first ischemic stroke of undetermined cause were 77% less likely to suffer subsequent vascular events, according to a recent study published in Neurology.View full resource at modernmedicine.com

  • View Related
  • Share

Most Recently Shared on August 17, 2011 at 9:09 pm By:

EndoNeuro Thomas Grobelny Physician, Doctor, Neurology, and Radiologist

Stroke News: Statins may reduce risk of recurrent vascular events in young stroke patients -... http://t.co/LeANuFI ChicagoEndovascular

8 months ago...

MedWire News - Stroke - Statins advised for young adults with stroke of unknown cause

medwire-news.md — “MedWire News Prescribing statins to young stroke survivors may reduce their risk for subsequent vascular events, even if the stroke etiology is unclear, researchers report in the journal Neurology. MedWire NewsView full resource at medwire-news.md

  • View Related
  • Share

Most Recently Shared on August 3, 2011 at 8:49 pm By:

Neurology_OW Neurology OW OW Health

Statins advised for young adults with stroke of unknown cause: Prescribing statins to young stroke survivors may... http://bit.ly/qYacrM

8 months ago...

6 Opportunities to Reduce Your Heart Disease Risk in August « Heart & Vascular

advancingyourhealth.org — “6 Opportunities to Reduce Your Heart Disease Risk in August « Heart & VascularView full resource at advancingyourhealth.org

  • View Related
  • Share

Most Recently Shared on August 2, 2011 at 3:02 pm By:

emoryhealthcare Emory Healthcare Healthcare System

Happy Tuesday! We're kicking off the day w/ 6 opportunities to reduce your risk for heart disease in August! http://bit.ly/HeartWiseAug

8 months ago...

WARFARIN Study initiated to assess utility of genetic testing to reduce warfarin-related adverse events

news-medical.net — “Iverson Genetic Diagnostics, Inc. announced that the WARFARIN Study was initiated at Colorado Heart & Vascular, P.C. in Denver and other major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on July 30, 2011 at 8:54 am By:

Medicare_News News-Medical.Net Health News

Medicare News: WARFARIN Study initiated to assess utility of genetic testing to reduce warfarin-related adverse ... http://bit.ly/r42Vqd

9 months ago...

Advertisement